autologous epcs transfected with human enos
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2013 (NCT00936819)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous epcs transfected with human enos
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03001414 | Phase 2 | Apr 1, 2017 | Northern Therapeutics, University of Ottawa |
| NCT00936819 | Phase 2 | Jul 1, 2013 | Canadian Institutes of Health Research (CIHR), University of Ottawa |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Ottawa | Academic/Hospital | 2 | 1 | 1 | 2013 |
| Canadian Institutes of Health Research (CIHR) | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Northern Therapeutics | For profit | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1